These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3602308)

  • 1. Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo.
    Preskorn SH; Weller EB; Hughes CW; Weller RA; Bolte K
    Psychopharmacol Bull; 1987; 23(1):128-33. PubMed ID: 3602308
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state plasma imipramine levels in prepubertal depressed children.
    Weller EB; Weller RA; Preskorn SH; Glotzbach R
    Am J Psychiatry; 1982 Apr; 139(4):506-8. PubMed ID: 7065300
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 6. Imipramine in prepubertal major depressive disorders.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Tabrizi MA; King J; Goetz R; Davies M; Stiller RL
    Arch Gen Psychiatry; 1987 Jan; 44(1):81-9. PubMed ID: 3541830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for in vivo methylation of the secondary amino antidepressant desipramine to imipramine in humans.
    Narasimhachari N; Saady JJ; Joseph A; Ettigi P; Friedel RO
    J Clin Psychopharmacol; 1982 Dec; 2(6):413-6. PubMed ID: 7174866
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum imipramine concentrations lower than plasma values.
    Hullett FJ; Levy AB; Tachiki KH
    J Clin Psychiatry; 1984 Dec; 45(12):516-8. PubMed ID: 6501238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine blood levels and clinical outcome.
    Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression, agoraphobia, and the DST.
    Stewart JT; Lawlor BA
    J Clin Psychiatry; 1985 Nov; 46(11):503-4. PubMed ID: 4055714
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine treatment of depressed children: a double-blind pilot study.
    Petti TA; Law W
    J Clin Psychopharmacol; 1982 Apr; 2(2):107-10. PubMed ID: 7042769
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings].
    Quitkin FM; Kane JM; Rifkin A; Ramos-Lorenzi JR; Saraf K; Howard A; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):142-4. PubMed ID: 7015396
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentration and clinical effect in imipramine treatment of childhood enuresis.
    Jorgensen OS; Lober M; Christiansen J; Gram LF
    Clin Pharmacokinet; 1980; 5(4):386-93. PubMed ID: 6994982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of imipramine and adverse effects in children.
    Preskorn SH; Weller EB; Weller RA; Glotzbach E
    Am J Psychiatry; 1983 Oct; 140(10):1332-5. PubMed ID: 6624965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.